2021 Annual Congress   |   Past & Future Meetings
  • China
  • India
  • London
  • New York
  • Paris
  • Tokyo
Virtual 6th Annual International Coronary Congress

Please note that all times below are listed in Eastern Standard Time.

9:00 am - 9:05 am
Welcome Remarks
9:05 am - 10:45 am
Session I
The Evolving Evidence Base and Basic Techniques for CABG in 2020
Introduction: Marc Moon, AATS President
John Puskas, ICC Course Co-Director
9:05 am - 9:17 am
The Role of Coronary Surgery in 2020: A Cardiologistís Perspective
Michael Farkouh
9:17 am - 9:29 am
The Role of Coronary Surgery in 2020: A Surgeonís Perspective
Mark Ruel
9:29 am - 9:41 am
The EXCEL Trial: Latest Implications for Left Main Disease and other Trials
David Taggart
9:41 am - 9:53 am
Only CABG Prolongs Life and Prevents MI in Stable Coronary Artery Disease
Faisal Bakaeen
9:53 am - 10:05 am
Bridging the Gap between Best Evidence and Common Practice in CABG: Simple Techniques to Consider in All Patients
John Puskas
10:05 am - 10:17 am
Best Practices for Vein Harvest, Storage and Grafting
Stephen Fremes
10:17 am - 10:29 am
Quality Assessment in 20 Years of Off-Pump CABG
Ki-Bong Kim
10:29 am - 10:45 am
Panel Discussion/Q & A
Panelists: Faisal Bakaeen, Michael Farkouh, Steve Fremes, Sanghon Jheon, Ki-Bong Kim, Marc Moon, John Puskas, Mark Ruel, David Taggart
10:45 am - 11:30 am
Industry Symposium supported by MEDISTIM
Introduction by David Taggart
Practical Imaging with the MiraQ System
Interaoperative High Frequency Ultrasound during CABG - a Practical Approach
11:30 am - 1:15 pm
Session II
Arterial Grafting
Introduction: Joseph Dearani, STS President
David Taggart, ICC Course Co-Director
Bashi Velayudhan, IACTS President
11:30 am - 11:42 am
The Evidence for Multiple and All-Arterial Grafting
Umberto Benedetto
11:42 am - 11:54 am
The Evidence for BITA Grafting: When and when not?
Joseph Sabik
11:54 am - 12:06 pm
Skeletonized BITA Harvest: Why and How? (Including the Harmonic Scalpel)
Teresa Kieser
12:06 pm - 12:18 pm
The Evidence for RA Grafting: When and when not?
Mario Gaudino
12:18 pm - 12:30 pm
How to Deploy ITA and RA Conduits
James Tatoulis
12:30 pm - 12:42 pm
Competitive Flow and other Pitfalls to Avoid in Arterial Grafting
David Glineur
12:42 pm - 1:00 pm
History of OPCAB: A Global Perspective
Old World: Paul Sergeant
New World: Michael Mack
1:00 pm - 1:15 pm
Panel Discussion/Q & A
Panelists: Hirokuni Arai, Joseph Dearani, Mario Gaudino, David Glineur, Teresa Kieser, Joseph Sabik, Paul Sergeant, Pitor Sulwaski, David Taggart, James Tatoulis, Bashi Velayudhan
1:15 pm - 1:25 pm
Lifetime Achievement Award 2020
Michael Mack Paul Sergeant
1:25 pm - 2:10 pm
Industry Symposium supported by Medtronic

Joseph McGinn

Live Q&A
Joseph McGinn
Robert Kiaii
2:10 pm - 3:45 pm
Session III
Complex Techniques in Surgical Coronary Revascularization
Introduction: Mario Gaudino, ICC Course Chair
Piotr Suwalski, ISMICS President
2:10 pm - 2:20 pm
Management of Diffuse CAD, Including Coronary Endarterectomy
Omprakash Yadava
2:20 pm - 2:30 pm
Coronary Stentectomy for Full Metal Jacket
Shuichiro Takanashi
2:30 pm - 2:40 pm
State-of-the-art CABG on Cardiopulmonary Bypass
Thierry Carrel
2:40 pm - 2:50 pm
The Evidence for/against OPCAB in 2020
David Taggart
2:50 pm - 3:00 pm
OPCAB: Surgical Principles
John Puskas
3:00 pm - 3:10 pm
Anaortic OPCAB: Why, When and How?
Michael Vallely
3:10 pm - 3:20 pm
Robotic MIDCAB, TECAB and Hybrid Coronary Revascularization
Husam Balkhy
3:20 pm - 3:30 pm
CABG and Atrial Fibrillation Ablation
Marc Gillinov
3:30 pm - 3:45 pm
Panel Discussion/Q & A
Panelists: Husam Balkhy, Thierry Carrel, Marc Gillinov, John Puskas, Piotr Suwalski, David Taggart, Shuichiro Takanashi, Michael Vallely, Omprakash Yadava, Zhe Zheng
3:45 pm - 4:30 pm
Industry Symposium supported by Atricure
Concomitant Treatment of AF in CABG; Is the Juice Worth the Squeeze?

Surgeon's top concomitant questions reviewed in a rapid-fire panel setting
  • What are the actual risks of adding concomitant treatment in CABG procedures?
  • What are the benefits of concomitant treatment in CABG procedures?
  • For patients with AF, should it be a complete CMIV or nothing at all?
  • For patients with multiple vessel disease and AF, does a second/third bypass or AF correction procedure have the greatest risk/benefit?
  • How should surgeons get up the learning curve?
  • What do referring physicians want us to do?
  • Should patients have input in the decision to treat their AFib during coronary bypass procedures?

Panelists: John Puskas, MD, Marc Gillinov, MD, Piotr Suwalski, MD, & Eric Okum, MD

4:30 pm
Closing Remarks & Announcement of ICC 2021
John Puskas, David Taggart